Fresenius Medical Care sells Spectra Laboratories assets to Quest Diagnostics
SOURCENews reportView the filing ↗
What we know
Based on news reporting.
Summary
Fresenius Medical Care agreed to sell select assets of Spectra Laboratories, its US laboratory testing business, to Quest Diagnostics as part of the FME25 transformation programme. Group-wide the portfolio exits covered 230 facilities and about 8,200 employees across Latin America, Sub-Saharan Africa, Turkiye, Australia and Spectra. Those employees transferred with the businesses to their new owners rather than losing their jobs, so no layoff headcount is recorded here.
LayoffTalk has tracked 3 layoff events at Spectra Labs since February 2025, including 192 jobs documented in official WARN filings, with 1 additional event known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Spectra Labs
Recent tracked events at this company.